Grimes & Company Inc. Sells 8,289 Shares of Agilent Technologies, Inc. (NYSE:A)

Grimes & Company Inc. lowered its position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 8.2% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 93,340 shares of the medical research company's stock after selling 8,289 shares during the quarter. Grimes & Company Inc.'s holdings in Agilent Technologies were worth $13,859,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. RFG Advisory LLC bought a new position in Agilent Technologies during the 1st quarter worth $261,000. Wealth Enhancement Advisory Services LLC lifted its position in Agilent Technologies by 2.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 25,107 shares of the medical research company's stock worth $3,653,000 after purchasing an additional 695 shares during the period. Kathmere Capital Management LLC acquired a new stake in Agilent Technologies during the first quarter worth about $243,000. S.E.E.D. Planning Group LLC grew its stake in Agilent Technologies by 2.4% during the first quarter. S.E.E.D. Planning Group LLC now owns 33,762 shares of the medical research company's stock worth $4,913,000 after buying an additional 795 shares in the last quarter. Finally, Occidental Asset Management LLC increased its holdings in Agilent Technologies by 0.9% in the 1st quarter. Occidental Asset Management LLC now owns 19,740 shares of the medical research company's stock valued at $2,872,000 after buying an additional 171 shares during the period. Institutional investors and hedge funds own 87.42% of the company's stock.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the company's stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total value of $283,910.00. Following the sale, the chief executive officer now owns 24,118 shares in the company, valued at $3,497,110. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, SVP Dominique Grau sold 9,990 shares of the business's stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at approximately $5,801,595. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company's stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares of the company's stock, valued at $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,953 shares of company stock valued at $2,013,630. Company insiders own 0.33% of the company's stock.

Wall Street Analysts Forecast Growth

A has been the topic of several analyst reports. Stifel Nicolaus reiterated a "buy" rating and set a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. UBS Group raised their target price on Agilent Technologies from $141.00 to $150.00 and gave the company a "neutral" rating in a report on Thursday, August 22nd. Evercore ISI boosted their price target on Agilent Technologies from $135.00 to $145.00 and gave the stock an "in-line" rating in a report on Tuesday, October 1st. TD Cowen raised their price objective on Agilent Technologies from $153.00 to $160.00 and gave the company a "buy" rating in a research note on Thursday, August 22nd. Finally, Barclays boosted their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an "underweight" rating in a research note on Tuesday, October 15th. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, Agilent Technologies currently has an average rating of "Moderate Buy" and an average price target of $144.36.

Agilent Technologies Trading Down 1.7 %

NYSE A traded down $2.31 during mid-day trading on Thursday, reaching $130.72. 1,830,061 shares of the stock were exchanged, compared to its average volume of 1,687,240. The stock has a market cap of $38.14 billion, a P/E ratio of 30.90, a P/E/G ratio of 6.96 and a beta of 1.05. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. Agilent Technologies, Inc. has a one year low of $96.80 and a one year high of $155.35. The stock has a 50 day simple moving average of $140.91 and a 200-day simple moving average of $138.59.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.26 by $0.06. The business had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The firm's revenue was down 5.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.43 earnings per share. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.24 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st were issued a $0.236 dividend. The ex-dividend date of this dividend was Tuesday, October 1st. This represents a $0.94 annualized dividend and a yield of 0.72%. Agilent Technologies's payout ratio is currently 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.